4
Changes in Ownership
Protalix BioTherapeutics, Inc. Filed Acc 0001144204-13-046628
Director sold 112,330 shares at an average $5.05 ($567,563)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Akirov Alfred Director | 2013-08-14 | Sale | −100,000 | $5.05 | $505,000 | 4,927,713 | I |
| Akirov Alfred Director | 2013-08-14 | Sale | −5,000 | $5.07 | $25,350 | 4,922,713 | I |
| Akirov Alfred Director | 2013-08-14 | Sale | −5,000 | $5.08 | $25,400 | 4,917,713 | I |
| Akirov Alfred Director | 2013-08-15 | Sale | −2,330 | $5.07 | $11,813 | 4,915,383 | I |
| Open-market sales · 112,330 sh · avg $5.05 · $567,563 | |||||||
Loading xslF345X03/v353216_4.xml…